http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102686721-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0623 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0081 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0602 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0618 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56966 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 |
| filingDate | 2010-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102686721-B |
| titleOfInvention | For the method and composition that the amplification of glial restricted progenitor cell in Mammals source, qualification, sign and usefulness strengthen |
| abstract | The invention provides the method for generation of people source glial restricted progenitor cell (GRP) group, described cell mass has the standard deviation in group's cell of may not wanting of minimizing or less desirable cell phenotype and/or reduction.Present invention also offers antibody group and the gene expression profile for characterizing GRP and characterizing the application method in GRP cell.In addition, the invention provides for using these GRP cells to produce stellate cell and/or oligodendroglia, neurone is formed again, and myelin and treatment neurogliocyte be correlated with and the method for other neurodegenerative disease or obstacle or neural damage or damage.Present invention also offers the manufacture method of the neurocyte of A2B5 positive cell disappearance. |
| priorityDate | 2009-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 140.